Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 vs enalapril in pediatric heart failure
CTR20181474Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in heart failure (HF), sponsored by Novartis. Started Nov 2018; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20181474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181474.